Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885192790> ?p ?o ?g. }
- W2885192790 endingPage "4868" @default.
- W2885192790 startingPage "4857" @default.
- W2885192790 abstract "Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study Ronald Wihal Oei,1,2,* Lulu Ye,1,2,* Juan Huang,1,2 Fangfang Kong,1,2 Tingting Xu,1,2 Chunying Shen,1,2 Xiaoshen Wang,1,2 Xiayun He,1,2 Lin Kong,1,2 Chaosu Hu,1,2 Hongmei Ying1,2 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China *These authors contributed equally to this work Purpose: To investigate the prognostic value of nutritional markers for survival in nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT), with or without chemotherapy. Patients and methods: This retrospective study included 412 NPC patients who received IMRT-based treatment. Weight loss (WL) during treatment, hemoglobin level (Hb) and serum albumin level (Alb) before treatment were measured. The prognostic values of these markers for overall survival (OS), locoregional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) were analyzed using Kaplan–Meier method and Cox proportional hazards regression analysis. Propensity score matching was performed to reduce the effect of confounders. Results: WL, Hb and Alb were significantly correlated with each other and inflammatory markers. Adjusted Cox regression analysis showed that critical weight loss (CWL) (WL≥5%) was an independent prognostic factor for OS (HR: 2.399, 95% CI: 1.267–4.540, P=0.007) and LRFS (HR: 2.041, 95% CI: 1.052–3.960, P=0.035), while low pretreatment Hb was independently associated with poor DMFS (HR: 2.031, 95% CI: 1.144–3.606, P=0.016). However, no significant correlation was found between Alb and survival in our study cohort. The prognostic value of these markers was further confirmed in the propensity-matched analysis. Conclusion: CWL, Hb and Alb have a significant impact on survival in NPC patients undergoing IMRT. They can be utilized in combination with conventional staging system to predict the prognosis of NPC patients treated with IMRT. Keywords: weight loss, hemoglobin, albumin, nasopharyngeal carcinoma, intensity-modulated radiotherapy, survival" @default.
- W2885192790 created "2018-08-22" @default.
- W2885192790 creator A5005180151 @default.
- W2885192790 creator A5010779961 @default.
- W2885192790 creator A5017039148 @default.
- W2885192790 creator A5028174364 @default.
- W2885192790 creator A5037365557 @default.
- W2885192790 creator A5040030849 @default.
- W2885192790 creator A5040287148 @default.
- W2885192790 creator A5041198325 @default.
- W2885192790 creator A5069842088 @default.
- W2885192790 creator A5079423095 @default.
- W2885192790 creator A5087473873 @default.
- W2885192790 date "2018-08-01" @default.
- W2885192790 modified "2023-10-18" @default.
- W2885192790 title "Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study" @default.
- W2885192790 cites W1517004562 @default.
- W2885192790 cites W1757407923 @default.
- W2885192790 cites W1912452341 @default.
- W2885192790 cites W191634815 @default.
- W2885192790 cites W1966522224 @default.
- W2885192790 cites W1970159404 @default.
- W2885192790 cites W1977708803 @default.
- W2885192790 cites W1982637977 @default.
- W2885192790 cites W1983651550 @default.
- W2885192790 cites W1998867833 @default.
- W2885192790 cites W2017286592 @default.
- W2885192790 cites W2019816136 @default.
- W2885192790 cites W2020950228 @default.
- W2885192790 cites W2028050936 @default.
- W2885192790 cites W2030940982 @default.
- W2885192790 cites W2032247757 @default.
- W2885192790 cites W2034913961 @default.
- W2885192790 cites W2036193982 @default.
- W2885192790 cites W2036814259 @default.
- W2885192790 cites W2056246755 @default.
- W2885192790 cites W2057749060 @default.
- W2885192790 cites W2059189052 @default.
- W2885192790 cites W2059451363 @default.
- W2885192790 cites W2062298873 @default.
- W2885192790 cites W2073096992 @default.
- W2885192790 cites W2081920128 @default.
- W2885192790 cites W2084486398 @default.
- W2885192790 cites W2094296644 @default.
- W2885192790 cites W2098908259 @default.
- W2885192790 cites W2102310008 @default.
- W2885192790 cites W2105779274 @default.
- W2885192790 cites W2115794884 @default.
- W2885192790 cites W2123105952 @default.
- W2885192790 cites W2125714271 @default.
- W2885192790 cites W2131590442 @default.
- W2885192790 cites W2145280166 @default.
- W2885192790 cites W2145430644 @default.
- W2885192790 cites W2148152153 @default.
- W2885192790 cites W2171228276 @default.
- W2885192790 cites W2183406142 @default.
- W2885192790 cites W2288945768 @default.
- W2885192790 cites W2318839575 @default.
- W2885192790 cites W2353835 @default.
- W2885192790 cites W2462359505 @default.
- W2885192790 cites W4210983491 @default.
- W2885192790 cites W4237572687 @default.
- W2885192790 doi "https://doi.org/10.2147/ott.s165133" @default.
- W2885192790 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6098427" @default.
- W2885192790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30147337" @default.
- W2885192790 hasPublicationYear "2018" @default.
- W2885192790 type Work @default.
- W2885192790 sameAs 2885192790 @default.
- W2885192790 citedByCount "11" @default.
- W2885192790 countsByYear W28851927902019 @default.
- W2885192790 countsByYear W28851927902020 @default.
- W2885192790 countsByYear W28851927902021 @default.
- W2885192790 countsByYear W28851927902022 @default.
- W2885192790 countsByYear W28851927902023 @default.
- W2885192790 crossrefType "journal-article" @default.
- W2885192790 hasAuthorship W2885192790A5005180151 @default.
- W2885192790 hasAuthorship W2885192790A5010779961 @default.
- W2885192790 hasAuthorship W2885192790A5017039148 @default.
- W2885192790 hasAuthorship W2885192790A5028174364 @default.
- W2885192790 hasAuthorship W2885192790A5037365557 @default.
- W2885192790 hasAuthorship W2885192790A5040030849 @default.
- W2885192790 hasAuthorship W2885192790A5040287148 @default.
- W2885192790 hasAuthorship W2885192790A5041198325 @default.
- W2885192790 hasAuthorship W2885192790A5069842088 @default.
- W2885192790 hasAuthorship W2885192790A5079423095 @default.
- W2885192790 hasAuthorship W2885192790A5087473873 @default.
- W2885192790 hasBestOaLocation W28851927901 @default.
- W2885192790 hasConcept C126322002 @default.
- W2885192790 hasConcept C143998085 @default.
- W2885192790 hasConcept C17923572 @default.
- W2885192790 hasConcept C2778997737 @default.
- W2885192790 hasConcept C50382708 @default.
- W2885192790 hasConcept C509974204 @default.
- W2885192790 hasConcept C71924100 @default.
- W2885192790 hasConceptScore W2885192790C126322002 @default.
- W2885192790 hasConceptScore W2885192790C143998085 @default.
- W2885192790 hasConceptScore W2885192790C17923572 @default.
- W2885192790 hasConceptScore W2885192790C2778997737 @default.